Voloridge Investment Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Voloridge Investment Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-21,770	Closed	-$216K	–	1635
2023 Q1	$216K	Buy	+21,770	New	+$216K	﹤0.01%	1304

Voloridge Investment Management's APEN Position: Q2 2023 in Review

Voloridge Investment Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 21,770 shares — an estimated $216K sold.

Voloridge Investment Management first reported a position in APEN in Q1 2023 and held it in 1 quarter. The position peaked at $216K in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Voloridge Investment Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Voloridge Investment Management sold 21,770 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $216K.
Voloridge Investment Management first reported a position in Apollo Endosurgery, Inc. in Q1 2023 and held it in 1 quarter.
Voloridge Investment Management's Apollo Endosurgery, Inc. position peaked at $216K in Q1 2023.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.